Stay up to date

Latest News

28th February 2026

Genotype-phenotype correlations of GFAP variants in type I Alexander disease subtypes

Alexander Disease https://www.sciencedirect.com/science/article/pii/S109671922500681X?via%3Dihub#ab0005 Alexander disease is a rare, progressive neurological condition caused by changes, known as variants, in the GFAP gene. This gene provides instructions for making glial fibrillary acidic protein (GFAP), a key structural protein in astrocytes, which are support cells in the brain. When GFAP is altered, it can form abnormal clumps called […]

28th February 2026

An AAV-Based Therapy Approach for Neurological Phenotypes of X-Linked Adrenoleukodystrophy

Adrenoleukodystrophy (ALD) https://www.mdpi.com/1422-0067/26/23/11645 X-linked adrenoleukodystrophy (X‑ALD) is a genetic condition caused by faults in the ABCD1 gene. Importantly, the type of mutation does not predict which form of the disease a person will develop. Current treatments are limited — stem cell transplantation only helps early cerebral ALD, and existing gene therapy approaches carry risks and […]

28th February 2026

Living with adrenoleukodystrophy: adult patient and caregiver perspectives

Adrenoleukodystrophy (ALD) https://pmc.ncbi.nlm.nih.gov/articles/PMC12781523 Adrenoleukodystrophy (ALD) is a rare, inherited condition caused by changes in the ABCD1 gene that leads to a build-up of very long chain fatty acids that damage the brain, spinal cord, and adrenal glands. Although ALD is often discussed in children, many adults, including both men and women, live for decades with […]

28th February 2026

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™

Krabbe Disease https://investors.polaryx.com/pr/polaryx-announces-key-preclinical-data-related-to-soteria-at-the-22nd-annual-worldsymposium Polaryx presented key pre-clinical data for PLX-200 their reformulated gemfibrozil drug in a Krabbe mouse model where it was found to reduce astrogliosis and neuro-inflammation, protect myelin, and reduce psychosine accumulation. Importantly, it also restored motor functions and increased lifespan in the Krabbe mice. These are encouraging results as later this year […]

28th February 2026

ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301 

Aicardi Goutières Syndrome (AGS) https://www.immunesensor.com/news/021226 ImmuneSensor Therapeutics recently successfully completed a control Phase 1a study in healthy volunteers to evaluate the safety, tolerability, pharmacokinetics (what the body does to the drug) and pharmacodynamics (what the drug does to the body) of their product IMSB301 a novel, potentially best-in-class, orally available small molecule cGAS inhibitor. It […]

24th February 2026

Research Summary: February 2026

Research summary of recent leukodystrophy research and clinical trials, includes article summaries and direct links to websites and articles. To access the summary: Research Summary – February 2026 Please be aware these summaries are produced voluntarily by Biomedical Science students and are their interpretations of the information and findings. This information is reviewed by our […]

31st January 2026

Recommended methods for the collection of clinical expert judgment in rare diseases: Generating evidence to support reimbursement of orphan drugs

Leukodystrophies https://pmc.ncbi.nlm.nih.gov/articles/PMC12592965 Developing new treatments for rare diseases is difficult because there are often very few patients and limited clinical data. This makes it challenging for healthcare decision-makers to judge whether new medicines are effective and represent good value for money. In these situations, the knowledge and experience of clinical experts, such as specialist doctors […]

31st January 2026

Patient passports for rare diseases: results of a pilot study

Leukodystrophies https://www.nature.com/articles/s41431-025-01930-w# People living with rare diseases often have complex medical needs and see many different healthcare professionals (HCPs) both in routine care and in emergency situations. Because many HCPs are unfamiliar with rare conditions, patients and caregivers often have to repeatedly explain their diagnosis, treatments and care needs, which can be stressful, time-consuming and […]

31st January 2026

Abnormal Splicing of GALC Transcripts Underlies Unusual Cases of Krabbe Disease

Krabbe Disease https://www.mdpi.com/2227-9059/13/12/3114 Krabbe disease is a rare inherited disorder that damages the nervous system by disrupting myelin, the protective coating around nerve fibres. It is caused by faults in the GALC gene, which normally produces the lysosomal enzyme galactosylceramidase. When this enzyme does not function as normal, toxic lipids accumulate, and progressive neurological symptoms […]

31st January 2026

A Diagnostic Blind Spot: Deep intronic SVA_E Insertion identified as the most Common Pathogenic Variant Associated with Canavan Disease

Canavan disease https://pmc.ncbi.nlm.nih.gov/articles/PMC12456746/#abstract1 Canavan disease is a rare, inherited neurological disorder that begins in early infancy and leads to progressive and irreversible loss of motor and cognitive abilities. It is caused by having two nonworking copies of the ASPA gene, which normally helps break down N-acetylaspartate. Although Canavan disease can often be diagnosed based on […]

31st January 2026

Sexual Dysfunction and Its Relationship With Hypogonadism and Myelopathy in Male Patients With X-Linked Adrenoleukodystrophy

Adrenoleukodystrophy (ALD) https://pmc.ncbi.nlm.nih.gov/articles/PMC12672194 This research study looks at sexual health problems in adult men living with X-linked adrenoleukodystrophy (X-ALD). X-ALD is a rare inherited condition that affects the brain, spinal cord, and hormone-producing glands. Many men with X-ALD develop long-term nerve problems that can cause stiffness, weakness in the legs, problems with walking, and changes […]

31st January 2026

Late-Onset X-linked Adrenoleukodystrophy: A Rare Cause of Progressive Spastic Paraparesis

Adrenoleukodystrophy (ALD) https://www.cureus.com/articles/443571-late-onset-x-linked-adrenoleukodystrophy-a-rare-cause-of-progressive-spastic-paraparesis#! X-linked Adrenoleukodystrophy (X-ALD) is a genetic condition in which certain fats build up in the body and gradually damage the brain, spinal cord and adrenal glands. Although it mainly affects men, women who carry a faulty ABCD1 gene can also develop symptoms later in life. In women, the condition usually progresses slowly […]